In the meta-analysis undertaken by Natto et al. (2019) [76] they suggested that n-3 supplementation may improve metabolic or inflammatory markers, e.g., TNF-α in patients with diabetes or cardiovascular disease, but their data was not conclusive, and furthermore they did not explore the effects of dose or time. The gene discussed is TNF; the disease is diabetes mellitus.